Kurland ES - Search Results

1

The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)].

Kurland ES, Heller SL, Diamond B, McMahon DJ, Cosman F, Bilezikian JP. Kurland ES, et al. Osteoporos Int. 2004 Dec;15(12):992-7. doi: 10.1007/s00198-004-1636-z. Epub 2004 Jun 3. Osteoporos Int. 2004. PMID: 15175844

2

Idiopathic osteoporosis in premenopausal women.

Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian JP, Shane E. Rubin MR, et al. Among authors: kurland es. Osteoporos Int. 2005 May;16(5):526-33. doi: 10.1007/s00198-004-1716-0. Epub 2004 Aug 5. Osteoporos Int. 2005. PMID: 15300364

3

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP. Kurland ES, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3069-76. doi: 10.1210/jcem.85.9.6818. J Clin Endocrinol Metab. 2000. PMID: 10999788 Clinical Trial.

4

Therapy of male osteoporosis with parathyroid hormone.

Bilezikian JP, Kurland ES. Bilezikian JP, et al. Among authors: kurland es. Calcif Tissue Int. 2001 Oct;69(4):248-51. doi: 10.1007/s00223-001-1041-y. Calcif Tissue Int. 2001. PMID: 11730261 Review.

5

Osteoporosis and low bone mass in premenopausal and perimenopausal women.

Moreira Kulak CA, Schussheim DH, McMahon DJ, Kurland E, Silverberg SJ, Siris ES, Bilezikian JP, Shane E. Moreira Kulak CA, et al. Among authors: kurland e. Endocr Pract. 2000 Jul-Aug;6(4):296-304. doi: 10.4158/EP.6.4.296. Endocr Pract. 2000. PMID: 11242606

6

Insulin-like growth factor-I in men with idiopathic osteoporosis.

Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP. Kurland ES, et al. J Clin Endocrinol Metab. 1997 Sep;82(9):2799-805. doi: 10.1210/jcem.82.9.4253. J Clin Endocrinol Metab. 1997. PMID: 9284699

7

Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I.

Kurland ES, Chan FK, Rosen CJ, Bilezikian JP. Kurland ES, et al. J Clin Endocrinol Metab. 1998 Jul;83(7):2576-9. doi: 10.1210/jcem.83.7.4971. J Clin Endocrinol Metab. 1998. PMID: 9661647 Clinical Trial.

8

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.

Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetić K, Müller R, Bilezikian J, Lindsay R. Dempster DW, et al. Among authors: kurland es. J Bone Miner Res. 2001 Oct;16(10):1846-53. doi: 10.1359/jbmr.2001.16.10.1846. J Bone Miner Res. 2001. PMID: 11585349 Free article.

9

Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES. Delany AM, et al. Among authors: kurland es. Osteoporos Int. 2008 Jul;19(7):969-78. doi: 10.1007/s00198-007-0523-9. Epub 2007 Dec 15. Osteoporos Int. 2008. PMID: 18084690 Free PMC article.

10

Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.

Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW, Nieves J, Shane E, Fratzl P, Klaushofer K, Bilezikian J, Lindsay R. Misof BM, et al. Among authors: kurland es. J Clin Endocrinol Metab. 2003 Mar;88(3):1150-6. doi: 10.1210/jc.2002-021988. J Clin Endocrinol Metab. 2003. PMID: 12629098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters